SEC Form 4 · accession 0001615774-16-004864
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Zachary McAdoo
Director
Period of report
Apr 5, 2016
Accepted (ET)
Apr 7, 2016 · 9:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 5, 2016 | A | 250,000 | $0.00 | A | 1,998,720 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F11,748,720 of these shares are held in the name of the Zanett Opportunity Fund, Ltd., which is managed by the McAdoo Capital Investments, of which the Reporting Person is the President.